Honasa Consumer Ltd. Share Price

Overview

Honasa Consumer Ltd. share price is currently ₹424.84, down by - ₹0.34 (0.08%) from its previous closing price of ₹425.18. The share price has declined -8.9% over the past month and gained 44.45% over the past year. The stock's 52-week low and high are ₹243.17 and ₹507.13, respectively. Honasa Consumer Ltd. has a market capitalisation of ₹ 15,180.00 Cr. The share price was last updated on 01 Oct 2026, 03:56 PM IST.

Honasa Consumer Ltd.
Honasa Consumer Ltd.
HONASA
 ₹0.00
- ₹0.34
0.08%
Trading
 ₹0.00(%)1D

Updated: 01 Oct 2026, 03:56:58 pm IST

Market Data

Open Price

 ₹426.80

Prev. Close

 ₹425.18
 ₹410.65

Day Low

 ₹427.97

Day High

 ₹243.17

52 Week Low

 ₹507.13

52 Week High

TradingTrading
CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

55.61

Sector PE

39.33

PB Ratio

10.10

Sector PB

4.45

EPS

7.64

Dividend Yield

1.01

Today's Volume

3.871 M

5 Day Avg. Volume

5.627 M

PEG Ratio

0.32

Market Cap.

₹ 15,180.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 30% at ₹3/Share
28-Aug-202628-Aug-2026

Mutual Fund Ownership

Mutual Fund Holder
Jul 26
Shares held
Aug 26
Shares held
Bandhan Large & Mid Cap Fund - Regular Plan - Growth20.00 Lac
28.01 Lac
(40.05%)
Helios Flexi Cap Fund - Regular Plan - Growth16.94 Lac
23.68 Lac
(39.77%)
Mirae Asset Great Consumer Fund - Regular Plan - Growth19.23 Lac
19.23 Lac
no change
Bandhan Innovation Fund - Regular Plan - Growth13.76 Lac
13.99 Lac
(1.69%)
Nippon India Innovation Fund - Regular Plan - Growth12.15 Lac
12.15 Lac
no change

About Honasa Consumer Ltd. 👋

Honasa Consumer Limited is an India-based beauty and personal care company, which is engaged in the trading of a variety of beauty and personal care products across baby care, skin care, hair and other related personal care categories, which are manufactured through third party contract manufacturers under the brand name of Mamaearth, The Derma Co., BBlunt, Aqualogica, Dr. Sheth's, STAZE, Reginald Men and Ayuga. Its flagship brand, Mamaearth, focuses on clean and toxin-free beauty products made with natural ingredients. The Derma Co. provides science-backed products powered by active ingredients. Aqualogica is a skin care brand that leverages the science of hydration to introduce products suited to Indian skin-types. BBlunt specializes in professional hair care and styling products. Dr. Sheth's focused on curating products that are designed for the Indian skin types. Staze 9to9 offers studio-finished makeup designed and curated for Indian skin types. It also owns CosmoGenesis.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Inderjeet Singh

Inderjeet Singh

29 Sep • 11:19 AM · SEBI-Registered Analyst

Honasa Consumer Shares Fall 3% After ₹643 Crore Block Deal

HONASA
shares fell around 3% on September 29 after about 1.4 crore shares, representing 4.4% of the company’s equity, changed hands in block deals worth ₹643.4 crore. The transaction was executed at ₹450 per share, a discount of around 3.4% to the previous close. The identities of the buyers and sellers were not immediately disclosed. The deal came a day after reports said Peak XV Partners, Sequoia Capital and Redwood Trust were likely to sell a combined 2.73% stake in Honasa Consumer through a block deal, with the proposed transaction valued at up to ₹400 crore and a floor price of ₹450 per share. Despite the block-deal-led decline, Honasa Consumer has reported an improvement in its financial performance. In Q1 FY27, the Mamaearth parent’s net profit more than doubled year-on-year to ₹90.45 crore, while revenue from operations increased 27% to ₹755.94 crore and EBITDA more than doubled to around ₹110 crore. The stock had also gained about 59.4% in 2026 before Tuesday’s decline.

See More
Finkhoz Roboadvisory Services

Finkhoz Roboadvisory Services

29 Sep • 10:35 AM · SEBI-Registered Analyst

Honasa Consumer falls 3% after ₹643 crore block deal

HONASA
Consumer Limited (HONASA) fell around 3% in early trade after a ₹643.4 crore block deal saw about 1.4 crore shares, or 4.4% of the company’s equity, change hands. The shares were transacted at ₹450 apiece, around 3.4% below the previous close. The large transaction has put selling pressure on the stock, with investors focusing on the identity of the seller and buyer and whether further stake sales could follow. Large block transactions can also increase near-term volatility, particularly when executed at a discount to the prevailing market price. The development comes after Honasa Consumer reported strong FY26 performance, with consolidated revenue rising 23% YoY to ₹657.1 crore in Q4 and full-year PAT increasing 176% to ₹200.2 crore. For investors, the key monitorables are the post-deal shareholding pattern, any further promoter or investor exits, trading volumes and whether the company's earnings growth continues to support the stock valuation. Overall, the ₹643.4 crore block deal is a key near-term overhang for Honasa Consumer. The focus now shifts to the identity of the transacting shareholders and whether the transaction is an isolated stake transfer or part of a larger exit. Disclosure: I do not hold any position in Honasa Consumer Limited. This post is for informational purposes only and is not investment advice.

See More
Tejaswi

Tejaswi

22 Sep • 3:42 PM · SEBI-Registered Analyst

Honasa: ad spend drops to 32% of sales, profit doubles

HONASA
Honasa Consumer Limited (NSE: HONASA), owner of Mamaearth and The Derma Co, posted record Q1 FY27 profit of ₹90.5 crore, up 119%. Revenue rose 27% to ₹755.9 crore. What happened Like for like revenue grew 32%. EBITDA nearly doubled to ₹110 crore. Ad spend rose 16.7% to ₹241 crore, slower than sales, falling to 31.8% of revenue from 34.6%. The Derma Co crossed a ₹1,000 crore yearly sales run rate, making it the group's second brand of that size. Focus categories like face wash, sunscreen and serums grew above 35%. Mamaearth grew in the high teens. Why it matters Younger buyers pick brands on social media, not on the shop shelf. Honasa was built for that. For a brand house, the test is whether sales grow faster than the ad budget. This quarter, they did. My view The profit story is simple. Every percentage point that advertising falls as a share of revenue adds about ₹30 crore a year to EBITDA at this scale. Nearly three points came off this quarter. That explains a big part of the jump. Two cautions. First, April to June is peak sunscreen season, and management itself flagged that some seasonal tailwinds may not repeat. Second, about ₹22 crore of other income helped the bottom line, nearly a quarter of net profit. A second ₹1,000 crore brand also cuts reliance on Mamaearth. At around ₹469, the stock trades near 60 times trailing earnings, up 54% in a year. That price needs ad spend to keep falling as a share of sales. What I am watching Q2 FY27 results in November, the ad spend ratio staying below 32%, and Mamaearth growth holding up. On the chart, ₹510 is the 52-week high and ₹420 is support. My stance: Hold. Add near ₹420, not at the highs. Disclosure: I do not hold a position in Honasa Consumer Limited at the time of writing. This is not investment advice.

See More
Finkhoz Roboadvisory Services

Finkhoz Roboadvisory Services

14 Sep • 4:34 PM · SEBI-Registered Analyst

Honasa (Mamaearth's parent) is a high-quality FMCG

HONASA
is a high-quality FMCG turnaround now firing — Finkhoz rates it 8.69/10 overall, #1 of 20 in its peer group, with a perfect Outlook (10), Robust Track Record (8.93) and Reasonable valuation (8.75), the only soft spot being Medium Reliability (7.19) owing to its short listed history and the FY25 "Project Neev" distribution overhaul (which caused a ₹65 Cr write-off). The business has posted four straight quarters of 20%+ revenue growth, capped by Q1 FY27's record ₹90.5 Cr profit (+119% YoY) on ₹756 Cr revenue (+27%), with profit compounding well ahead of sales on operating leverage (margin +585 bps). Growth is broad-based — The Derma Co. crossed ₹1,000 Cr ARR, Mamaearth re-accelerated to high-teens, and offline reach hit 2.5 lakh+ outlets. The catch is a premium ~62x trailing P/E (vs ~44x segment) that leaves no room for a stumble. Net: a genuine growth compounder, but priced like one — not a value entry.

See More
SASI KUMAR SEBI RA

SASI KUMAR SEBI RA

27 Aug • 8:11 AM · SEBI-Registered Analyst

Pre Market Report & Global Cues | 27 August, 2026

Global cues are slightly weak this morning, but nothing too negative. US markets ended almost flat. There was no strong buying, looks like the market is just taking a pause after the recent move. US 10Y yield is around 4.7% and the dollar index is near 99, both are stable. Asian markets are mixed. South Korea and Taiwan are in green, while Japan, Hong Kong and Singapore are slightly down. So overall, no clear direction from Asia. Still, Gift Nifty is indicating a 140–160 point gap-up, so we may see a positive start. Crude has cooled a bit. Brent is around $86, after being near $92–94 just a couple of days back. That’s some relief, but still on the higher side. One thing to watch is IT stocks. Infosys ADR (-2.8%) and Wipro ADR (-2.6%) closed lower, so IT may see some pressure in early trade. There will be stock-specific action today. 1. BEL continues to stay in focus with strong order flow. 2. IRB Infra will be watched after approving a ₹351 Cr investment into its InvIT. 3. NBCC is active with fresh project wins. 4. Juniper Green Energy also in focus after a long-term power agreement. On the weaker side: 1. Max Healthcare may see pressure due to a GST notice. 2. ICICI Prudential AMC could be under pressure due to a ₹3,100 Cr stake sale plan. 3. Honasa Consumer remains in focus after calling off its acquisition. From a sector side: IT may stay weak, while energy stocks will react to crude movement. Today's View: Even though global markets are not very strong, the start looks positive. The key will be whether Nifty can hold the gap-up. If selling comes at higher levels, the move may not sustain. Stock-specific action is likely to dominate today.

See More
SASI KUMAR SEBI RA

SASI KUMAR SEBI RA

26 Aug • 7:50 AM · SEBI-Registered Analyst

Pre Market Report & Global Cues | 26 August, 2026

Global cues are positive this morning. US markets closed higher, with Nasdaq up 0.66%, S&P up 0.32% and Dow up 0.30%. The move was supported by steady buying in tech and easing pressure from bond yields, which are around 4.65%. Asian markets are also largely positive. Hang Seng, Kospi and Shanghai are trading in gains, while only Straits Times is slightly in the red. Reflecting this, Gift Nifty is indicating a strong 150–200 point gap-up, suggesting a firm start for Nifty. One important support is coming from crude. Brent has fallen to around $85.5, which is a good sign for India as it reduces cost pressure. At the same time, the rupee is near 95.4 against the dollar and continues to stay at weak levels, which needs to be watched. There will be good stock-specific action today. In the power and renewable space, Suzlon Energy is in focus after a fresh order win. Ceigall India has received a ₹704 crore highway project, which can keep the stock active. Dabur India gets some relief as the court has stayed the labelling issue for now. Axis Bank may also see some interest after regulatory proceedings were closed. On the negative side, Cipla will be watched after USFDA observations at its plant. Honasa Consumer (Mamaearth) is also in focus after calling off a planned acquisition. Sector-wise, power, OMCs and aviation may see buying interest due to lower crude prices. Pharma stocks could remain stock-specific based on regulatory updates. There are no major domestic events today, so global cues and stock-specific news will drive the market. For today’s session: With strong global support and a positive start expected, Nifty may try to build on momentum. The key will be whether it sustains above 24,400–24,450 zone after the gap-up. If selling comes at higher levels, that will decide how much of the gains can hold.

See More

Frequently Asked Questions

What is the share price of Honasa Consumer Ltd.?

What is the market cap of Honasa Consumer Ltd.?

Should I buy Honasa Consumer Ltd. stock now?

What is the 52 week high and low of Honasa Consumer Ltd.?

Is the Honasa Consumer Ltd. stock good to buy?

Is Honasa Consumer Ltd. a good buy for the long term?

Is Honasa Consumer Ltd. overvalued or undervalued?

What is the PE and PB ratio of Honasa Consumer Ltd.?

Start Now